Jr. Michael Conick Hanley - Chief Business Officer at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jr. Michael Conick Hanley since 9/17/2023

Holdings reported by Jr. Michael Conick Hanley for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 36.2K $20.3K $0.56 Jun 8, 2022 Direct
Employee Stock Option (right to buy) 500K Feb 23, 2023 Direct Common Stock

Transactions reported by Jr. Michael Conick Hanley for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.